ArticleCancers2023
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling.
Fabiola Cecchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleCancers2023
Fabiola Cecchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.